Menin Inhibition With Revumenib for <i>KMT2A</i> -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Ghayas C. Issa, Ibrahim Aldoss, Michael J. Thirman, John DiPersio, Martha Arellano, James S. Blachly, Gabriel N. Mannis, Alexander Perl, David S. Dickens, Christine M. McMahon, Elie Traer, C. Michel Zwaan, Carolyn S. Grove, Richard Stone, Paul J. Shami, Ioannis Mantzaris, Matthew Greenwood, Neerav Shukla, Branko Cuglievan, Tibor Kovacsovics, Yu Gu, Rebecca G. Bagley, Kate Madigan, Yakov Chudnovsky, Huy Van Nguyen, Nicole McNeer, Eytan M. Stein, Andrew Wei, Shaun Fleming, Himalee Sabins, Ibrahim Aldoss, Tibor Kovacsovics, Richard Stone, Martha Arellano, Manish Patel, Chetasi Talati, Jing Chen, Boaz Nachmias, Mael Heiblig, Pau Montesios Fernandez, Montserrat Arnan-Sangerman, Eytan M. Stein, Ioannis Mantzaris, James S. Blachly, Elie Traer, C. Michael Zwaan, Ofir Wolach, Giovanni Marconi, Ashish Bajel, Carolyn S. Grove, Gabriel N. Mannis, Andre Schuh, Michael Thirman, John Byrd, Christine M. McMahon, David S. Dickens, Alexander Perl, Matthew Greenwood, Ghayas C. Issa, James Whitlock, Paul J. Shami, John DiPersio

Open source

DOI
10.1200/jco.24.00826
Published
2025-01
Container
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco.24.00826,
  title = {Menin Inhibition With Revumenib for
                    <i>KMT2A</i>
                    -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)},
  author = {Ghayas C. Issa and Ibrahim Aldoss and Michael J. Thirman and John DiPersio and Martha Arellano and James S. Blachly and Gabriel N. Mannis and Alexander Perl and David S. Dickens and Christine M. McMahon and Elie Traer and C. Michel Zwaan and Carolyn S. Grove and Richard Stone and Paul J. Shami and Ioannis Mantzaris and Matthew Greenwood and Neerav Shukla and Branko Cuglievan and Tibor Kovacsovics and Yu Gu and Rebecca G. Bagley and Kate Madigan and Yakov Chudnovsky and Huy Van Nguyen and Nicole McNeer and Eytan M. Stein and Andrew Wei and Shaun Fleming and Himalee Sabins and Ibrahim Aldoss and Tibor Kovacsovics and Richard Stone and Martha Arellano and Manish Patel and Chetasi Talati and Jing Chen and Boaz Nachmias and Mael Heiblig and Pau Montesios Fernandez and Montserrat Arnan-Sangerman and Eytan M. Stein and Ioannis Mantzaris and James S. Blachly and Elie Traer and C. Michael Zwaan and Ofir Wolach and Giovanni Marconi and Ashish Bajel and Carolyn S. Grove and Gabriel N. Mannis and Andre Schuh and Michael Thirman and John Byrd and Christine M. McMahon and David S. Dickens and Alexander Perl and Matthew Greenwood and Ghayas C. Issa and James Whitlock and Paul J. Shami and John DiPersio},
  year = {2025},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.24.00826},
  url = {https://doi.org/10.1200/jco.24.00826}
}

RIS

TY  - JOUR
TI  - Menin Inhibition With Revumenib for
                    <i>KMT2A</i>
                    -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)
AU  - Ghayas C. Issa
AU  - Ibrahim Aldoss
AU  - Michael J. Thirman
AU  - John DiPersio
AU  - Martha Arellano
AU  - James S. Blachly
AU  - Gabriel N. Mannis
AU  - Alexander Perl
AU  - David S. Dickens
AU  - Christine M. McMahon
AU  - Elie Traer
AU  - C. Michel Zwaan
AU  - Carolyn S. Grove
AU  - Richard Stone
AU  - Paul J. Shami
AU  - Ioannis Mantzaris
AU  - Matthew Greenwood
AU  - Neerav Shukla
AU  - Branko Cuglievan
AU  - Tibor Kovacsovics
AU  - Yu Gu
AU  - Rebecca G. Bagley
AU  - Kate Madigan
AU  - Yakov Chudnovsky
AU  - Huy Van Nguyen
AU  - Nicole McNeer
AU  - Eytan M. Stein
AU  - Andrew Wei
AU  - Shaun Fleming
AU  - Himalee Sabins
AU  - Ibrahim Aldoss
AU  - Tibor Kovacsovics
AU  - Richard Stone
AU  - Martha Arellano
AU  - Manish Patel
AU  - Chetasi Talati
AU  - Jing Chen
AU  - Boaz Nachmias
AU  - Mael Heiblig
AU  - Pau Montesios Fernandez
AU  - Montserrat Arnan-Sangerman
AU  - Eytan M. Stein
AU  - Ioannis Mantzaris
AU  - James S. Blachly
AU  - Elie Traer
AU  - C. Michael Zwaan
AU  - Ofir Wolach
AU  - Giovanni Marconi
AU  - Ashish Bajel
AU  - Carolyn S. Grove
AU  - Gabriel N. Mannis
AU  - Andre Schuh
AU  - Michael Thirman
AU  - John Byrd
AU  - Christine M. McMahon
AU  - David S. Dickens
AU  - Alexander Perl
AU  - Matthew Greenwood
AU  - Ghayas C. Issa
AU  - James Whitlock
AU  - Paul J. Shami
AU  - John DiPersio
PY  - 2025
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.24.00826
UR  - https://doi.org/10.1200/jco.24.00826
ER  - 

APA

Issa, G. C., Aldoss, I., Thirman, M. J., DiPersio, J., Arellano, M., Blachly, J. S., Mannis, G. N., Perl, A., Dickens, D. S., McMahon, C. M., Traer, E., Zwaan, C. M., Grove, C. S., Stone, R., Shami, P. J., Mantzaris, I., Greenwood, M., Shukla, N., Cuglievan, B., Kovacsovics, T., Gu, Y., Bagley, R. G., Madigan, K., Chudnovsky, Y., Nguyen, H. V., McNeer, N., Stein, E. M., Wei, A., Fleming, S., Sabins, H., Aldoss, I., Kovacsovics, T., Stone, R., Arellano, M., Patel, M., Talati, C., Chen, J., Nachmias, B., Heiblig, M., Fernandez, P. M., Arnan-Sangerman, M., Stein, E. M., Mantzaris, I., Blachly, J. S., Traer, E., Zwaan, C. M., Wolach, O., Marconi, G., Bajel, A., Grove, C. S., Mannis, G. N., Schuh, A., Thirman, M., Byrd, J., McMahon, C. M., Dickens, D. S., Perl, A., Greenwood, M., Issa, G. C., Whitlock, J., Shami, P. J., & DiPersio, J. (2025). Menin Inhibition With Revumenib for <i>KMT2A</i> -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101). Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00826

Source records